Funded Tech Companies
Breye Therapeutics
Headquartered in Denmark, Breye Therapeutics is venture-backed, with investment from BioInnovation Institute, Sound Bioventures and Novo Holdings.
Company Overview
Company Name
Breye Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
Denmark, SC Undisclosed
USA
Denmark, SC Undisclosed
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Breye Therapeutics is a clinical stage clinical biopharmaceutical company developing novel oral therapies for retinal vascular diseases within ophthalmology. Breye has two novel and relevant small molecule oral therapies to address large unmet medical needs in both diabetic retinopathy (DR) and age-related macular degeneration (AMD)
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/11/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ulrik Mouritzen
Company Investors
- BioInnovation Institute
- Sound Bioventures (Johan Kördel)
- Novo Holdings (Jørgen Petersen)
- Innovation Fund Denmark
- Vaekstfonden
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs